These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34658958)

  • 21. Early identification of autism in fragile X syndrome: a review.
    McCary LM; Roberts JE
    J Intellect Disabil Res; 2013 Sep; 57(9):803-14. PubMed ID: 22974167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.
    Westmark CJ; Sokol DK; Maloney B; Lahiri DK
    Mol Psychiatry; 2016 Oct; 21(10):1333-41. PubMed ID: 27573877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
    Toft AK; Lundbye CJ; Banke TG
    J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragile X syndrome as a rare disease in China - Therapeutic challenges and opportunities.
    Jin X; Chen L
    Intractable Rare Dis Res; 2015 Feb; 4(1):39-48. PubMed ID: 25674387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile X Syndrome: Prevalence, Treatment, and Prevention in China.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    Front Neurol; 2017; 8():254. PubMed ID: 28634468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social communication and theory of mind in boys with autism and fragile x syndrome.
    Losh M; Martin GE; Klusek J; Hogan-Brown AL; Sideris J
    Front Psychol; 2012; 3():266. PubMed ID: 22934085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac autonomic regulation in autism and Fragile X syndrome: a review.
    Klusek J; Roberts JE; Losh M
    Psychol Bull; 2015 Jan; 141(1):141-75. PubMed ID: 25420222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling fragile X syndrome in the laboratory setting: A behavioral perspective.
    Melancia F; Trezza V
    Behav Brain Res; 2018 Sep; 350():149-163. PubMed ID: 29704597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.
    Lozano R; Martinez-Cerdeno V; Hagerman RJ
    Curr Pharm Des; 2015; 21(34):4972-4979. PubMed ID: 26365141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis.
    Luu S; Province H; Berry-Kravis E; Hagerman R; Hessl D; Vaidya D; Lozano R; Rosselot H; Erickson C; Kaufmann WE; Budimirovic DB
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32932789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile x syndrome and autism spectrum disorder.
    Oberman L; Ifert-Miller F; Najib U; Bashir S; Woollacott I; Gonzalez-Heydrich J; Picker J; Rotenberg A; Pascual-Leone A
    Front Synaptic Neurosci; 2010; 2():26. PubMed ID: 21423512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome.
    Lee M; Martin GE; Berry-Kravis E; Losh M
    J Neurodev Disord; 2016; 8():47. PubMed ID: 28050218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Biomarkers in Fragile X Syndrome.
    Zafarullah M; Tassone F
    Brain Sci; 2019 Apr; 9(5):. PubMed ID: 31035599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment.
    Rajaratnam A; Potter LA; Biag HMB; Schneider A; Petrasic IC; Hagerman RJ
    Front Neurol; 2020; 11():581429. PubMed ID: 33193037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.
    Ouyang L; Grosse SD; Riley C; Bolen J; Bishop E; Raspa M; Bailey DB
    Res Dev Disabil; 2014 Jul; 35(7):1518-27. PubMed ID: 24755230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal profiles of expressive vocabulary, syntax and pragmatic language in boys with fragile X syndrome or Down syndrome.
    Martin GE; Losh M; Estigarribia B; Sideris J; Roberts J
    Int J Lang Commun Disord; 2013; 48(4):432-43. PubMed ID: 23889838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome.
    Jasoliya M; Bowling H; Petrasic IC; Durbin-Johnson B; Klann E; Bhattacharya A; Hagerman R; Tassone F
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32531912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translating precision medicine for autism spectrum disorder: A pressing need.
    Pérez-Cano L; Azidane Chenlo S; Sabido-Vera R; Sirci F; Durham L; Guney E
    Drug Discov Today; 2023 Mar; 28(3):103486. PubMed ID: 36623795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visuo-spatial construction trajectories in Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD): Evidence of cognitive heterogeneity within neurodevelopmental conditions.
    Ballantyne CJ; Núñez M; Manoussaki K
    Res Dev Disabil; 2017 Nov; 70():113-125. PubMed ID: 28923376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.